DNA Script
Le Kremlin-bicêtre
About DNA Script
DNA Script is a disruptive DNA synthesis company engineering biology to accelerate breakthroughs in life science and human health. Their revolutionary enzymatic technology powers the world's first benchtop DNA printer, SYNTAX, enabling labs to print their own synthetic oligos for greater workflow control and faster access to results.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $50K – $100K
- Total funding: $319.5M
- Funding stage: Seed
- Last round: Grant (Feb 2025)
- Website: dnascript.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/dna-script-105362 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.